Tirzepatide emerges a groundbreaking pharmaceutical agent for individuals struggling type 2 diabetes. As a dual receptor activator, it targets both the glucagon-like peptide-1 (GLP-1) and glucose-dependent https://marvintbeo811345.vidublog.com/39321155/tirzepatide-a-game-changer-for-type-2-diabetes